HERBALIFE LTD. Quarterly Liabilities, Current in USD from Q2 2010 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Herbalife Ltd. quarterly Liabilities, Current history and growth rate from Q2 2010 to Q4 2024.
Herbalife Ltd. Liabilities, Current for the quarter ending December 31, 2024 was $1.23B, a 3.69% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$1.23B	-$47.2M	-3.69%	Dec 31, 2024	10-K	2025-02-19
Q3 2024	$1.29B	+$120M	+10.3%	Sep 30, 2024	10-Q	2024-10-30
Q2 2024	$976M	-$265M	-21.3%	Jun 30, 2024	10-Q	2024-07-31
Q1 2024	$945M	-$283M	-23%	Mar 31, 2024	10-Q	2024-05-01
Q4 2023	$1.28B	+$301M	+30.8%	Dec 31, 2023	10-K	2025-02-19
Q3 2023	$1.17B	+$180M	+18.3%	Sep 30, 2023	10-Q	2023-11-01
Q2 2023	$1.24B	+$187M	+17.7%	Jun 30, 2023	10-Q	2023-08-02
Q1 2023	$1.23B	+$128M	+11.6%	Mar 31, 2023	10-Q	2023-05-02
Q4 2022	$977M	-$104M	-9.61%	Dec 31, 2022	10-K	2024-02-14
Q3 2022	$986M	-$53.1M	-5.11%	Sep 30, 2022	10-Q	2022-10-31
Q2 2022	$1.05B	-$33.9M	-3.12%	Jun 30, 2022	10-Q	2022-08-02
Q1 2022	$1.1B	+$32.4M	+3.04%	Mar 31, 2022	10-Q	2022-05-03
Q4 2021	$1.08B	-$46.9M	-4.16%	Dec 31, 2021	10-K	2023-02-14
Q3 2021	$1.04B	-$54.1M	-4.95%	Sep 30, 2021	10-Q	2021-11-02
Q2 2021	$1.09B	-$14.8M	-1.34%	Jun 30, 2021	10-Q	2021-08-03
Q1 2021	$1.07B	+$82.8M	+8.41%	Mar 31, 2021	10-Q	2021-05-04
Q4 2020	$1.13B	+$163M	+16.9%	Dec 31, 2020	10-K	2022-02-23
Q3 2020	$1.09B	+$172M	+18.7%	Sep 30, 2020	10-Q	2020-11-05
Q2 2020	$1.1B	-$424M	-27.8%	Jun 30, 2020	10-Q	2020-08-06
Q1 2020	$984M	-$547M	-35.7%	Mar 31, 2020	10-Q	2020-05-07
Q4 2019	$964M	-$624M	-39.3%	Dec 31, 2019	10-K	2021-02-17
Q3 2019	$921M	-$625M	-40.5%	Sep 30, 2019	10-Q	2019-10-29
Q2 2019	$1.53B	-$43.5M	-2.77%	Jun 30, 2019	10-Q	2019-08-01
Q1 2019	$1.53B	+$620M	+68.1%	Mar 31, 2019	10-Q	2019-05-02
Q4 2018	$1.59B	+$682M	+75.2%	Dec 31, 2018	10-K	2020-02-18
Q3 2018	$1.55B	+$687M	+80%	Sep 30, 2018	10-Q	2018-10-30
Q2 2018	$1.57B	+$707M	+82%	Jun 30, 2018	10-Q	2018-08-01
Q1 2018	$911M	-$29.7M	-3.16%	Mar 31, 2018	10-Q	2018-05-03
Q4 2017	$907M	+$115M	+14.6%	Dec 31, 2017	10-K	2019-02-19
Q3 2017	$859M	-$405M	-32%	Sep 30, 2017	10-Q	2017-11-02
Q2 2017	$863M	-$595M	-40.8%	Jun 30, 2017	10-Q	2017-08-01
Q1 2017	$941M	-$267M	-22.1%	Mar 31, 2017	10-Q	2017-05-04
Q4 2016	$792M	-$233M	-22.7%	Dec 31, 2016	10-K	2018-02-22
Q3 2016	$1.26B	+$233M	+22.6%	Sep 30, 2016	10-Q	2016-11-01
Q2 2016	$1.46B	+$360M	+32.8%	Jun 30, 2016	10-Q	2016-08-03
Q1 2016	$1.21B	+$39M	+3.34%	Mar 31, 2016	10-Q	2016-05-05
Q4 2015	$1.02B	+$150M	+17.1%	Dec 31, 2015	10-K	2017-02-23
Q3 2015	$1.03B	+$102M	+11%	Sep 30, 2015	10-Q	2015-11-03
Q2 2015	$1.1B	+$155M	+16.5%	Jun 30, 2015	10-Q	2015-08-05
Q1 2015	$1.17B	+$267M	+29.6%	Mar 31, 2015	10-Q	2015-05-05
Q4 2014	$875M	-$47.5M	-5.15%	Dec 31, 2014	10-K	2016-02-25
Q3 2014	$928M	+$60.1M	+6.92%	Sep 30, 2014	10-Q	2014-11-03
Q2 2014	$942M	+$150M	+18.9%	Jun 30, 2014	10-Q	2014-07-28
Q1 2014	$902M	+$160M	+21.5%	Mar 31, 2014	10-Q	2014-04-28
Q4 2013	$922M	+$160M	+21%	Dec 31, 2013	10-K	2015-02-26
Q3 2013	$868M	+$204M	+30.7%	Sep 30, 2013	10-Q/A	2013-12-16
Q2 2013	$792M	+$226M	+39.9%	Jun 30, 2013	10-Q/A	2013-12-16
Q1 2013	$742M	+$176M	+31.1%	Mar 31, 2013	10-Q/A	2013-12-16
Q4 2012	$762M	+$183M	+31.5%	Dec 31, 2012	10-K	2014-02-18
Q3 2012	$664M	+$113M	+20.6%	Sep 30, 2012	10-Q	2012-10-29

Previous1 2Next

Showing 1 to 50 of 59 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.